Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 29.1 CHF 0.69% Market Closed
Market Cap: 167.1m CHF
Have any thoughts about
Xlife Sciences AG?
Write Note

Intrinsic Value

XLS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one XLS stock under the Base Case scenario is 1.37 CHF. Compared to the current market price of 29.1 CHF, Xlife Sciences AG is Overvalued by 95%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

XLS Intrinsic Value
1.37 CHF
Overvaluation 95%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Xlife Sciences AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for XLS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about XLS?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Xlife Sciences AG

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Xlife Sciences AG

Provide an overview of the primary business activities
of Xlife Sciences AG.

What unique competitive advantages
does Xlife Sciences AG hold over its rivals?

What risks and challenges
does Xlife Sciences AG face in the near future?

Has there been any significant insider trading activity
in Xlife Sciences AG recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Xlife Sciences AG.

Provide P/S
for Xlife Sciences AG.

Provide P/E
for Xlife Sciences AG.

Provide P/OCF
for Xlife Sciences AG.

Provide P/FCFE
for Xlife Sciences AG.

Provide P/B
for Xlife Sciences AG.

Provide EV/S
for Xlife Sciences AG.

Provide EV/GP
for Xlife Sciences AG.

Provide EV/EBITDA
for Xlife Sciences AG.

Provide EV/EBIT
for Xlife Sciences AG.

Provide EV/OCF
for Xlife Sciences AG.

Provide EV/FCFF
for Xlife Sciences AG.

Provide EV/IC
for Xlife Sciences AG.

Show me price targets
for Xlife Sciences AG made by professional analysts.

What are the Revenue projections
for Xlife Sciences AG?

How accurate were the past Revenue estimates
for Xlife Sciences AG?

What are the Net Income projections
for Xlife Sciences AG?

How accurate were the past Net Income estimates
for Xlife Sciences AG?

What are the EPS projections
for Xlife Sciences AG?

How accurate were the past EPS estimates
for Xlife Sciences AG?

What are the EBIT projections
for Xlife Sciences AG?

How accurate were the past EBIT estimates
for Xlife Sciences AG?

Compare the revenue forecasts
for Xlife Sciences AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Xlife Sciences AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Xlife Sciences AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Xlife Sciences AG compared to its peers.

Compare the P/E ratios
of Xlife Sciences AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Xlife Sciences AG with its peers.

Analyze the financial leverage
of Xlife Sciences AG compared to its main competitors.

Show all profitability ratios
for Xlife Sciences AG.

Provide ROE
for Xlife Sciences AG.

Provide ROA
for Xlife Sciences AG.

Provide ROIC
for Xlife Sciences AG.

Provide ROCE
for Xlife Sciences AG.

Provide Gross Margin
for Xlife Sciences AG.

Provide Operating Margin
for Xlife Sciences AG.

Provide Net Margin
for Xlife Sciences AG.

Provide FCF Margin
for Xlife Sciences AG.

Show all solvency ratios
for Xlife Sciences AG.

Provide D/E Ratio
for Xlife Sciences AG.

Provide D/A Ratio
for Xlife Sciences AG.

Provide Interest Coverage Ratio
for Xlife Sciences AG.

Provide Altman Z-Score Ratio
for Xlife Sciences AG.

Provide Quick Ratio
for Xlife Sciences AG.

Provide Current Ratio
for Xlife Sciences AG.

Provide Cash Ratio
for Xlife Sciences AG.

What is the historical Revenue growth
over the last 5 years for Xlife Sciences AG?

What is the historical Net Income growth
over the last 5 years for Xlife Sciences AG?

What is the current Free Cash Flow
of Xlife Sciences AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Xlife Sciences AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Xlife Sciences AG

Current Assets 17.9m
Cash & Short-Term Investments 99.8k
Receivables 17.8m
Other Current Assets 45.9k
Non-Current Assets 491.9m
Long-Term Investments 214.4m
PP&E 376.6k
Intangibles 277.1m
Current Liabilities 6.7m
Accounts Payable 825.8k
Other Current Liabilities 5.8m
Non-Current Liabilities 230.4m
Long-Term Debt 53.2m
Other Non-Current Liabilities 177.2m
Efficiency

Earnings Waterfall
Xlife Sciences AG

Revenue
990.3k CHF
Cost of Revenue
-450.9k CHF
Gross Profit
539.3k CHF
Operating Expenses
-19.2m CHF
Operating Income
-18.7m CHF
Other Expenses
39.9m CHF
Net Income
21.2m CHF

Free Cash Flow Analysis
Xlife Sciences AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

XLS Profitability Score
Profitability Due Diligence

Xlife Sciences AG's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Positive Net Income
Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive 3-Year Average ROE
44/100
Profitability
Score

Xlife Sciences AG's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

XLS Solvency Score
Solvency Due Diligence

Xlife Sciences AG's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
38/100
Solvency
Score

Xlife Sciences AG's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XLS Price Targets Summary
Xlife Sciences AG

There are no price targets for XLS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for XLS?

Click here to dive deeper.

Dividends

Xlife Sciences AG
does not pay dividends
Shareholder Yield

Current shareholder yield for XLS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

XLS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Xlife Sciences AG Logo
Xlife Sciences AG

Country

Switzerland

Industry

Life Sciences Tools & Services

Market Cap

164.8m CHF

Dividend Yield

0%

Description

Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Zuerich and currently employs 19 full-time employees. The company went IPO on 2019-09-30. The firm focuses on investing in technologies in the life science industry. The company supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The firm offers its investors direct access to the further development of technologies at a very early stage. The firm cooperates with industrial partners and universities.

Contact

ZUERICH
Zurich
Talacker 35
+41443858460
www.xlifesciences.ch

IPO

2019-09-30

Employees

19

Officers

CEO & Executive Director
Mr. Oliver R. Baumann
Chief Financial Officer
Mr. Carl von Halem
Head of Accounting & Taxation
Mr. Beat Klaui
Head of Technology & Innovation
Dr. Alexander Zink
Chief Scientific Officer
Dr. Frank Ploger
Senior Communications & Investor Relations Manager
Dr. Dennis Fink
Show More
Chief Compliance Officer and Head of Legal & Compliance
Mr. Christian Faber
Show Less

See Also

Discover More
What is the Intrinsic Value of one XLS stock?

The intrinsic value of one XLS stock under the Base Case scenario is 1.37 CHF.

Is XLS stock undervalued or overvalued?

Compared to the current market price of 29.1 CHF, Xlife Sciences AG is Overvalued by 95%.

Back to Top